Lone hepatitis C virus myocarditis responsive to immunosuppressive therapy

Chest

Volumn 122, Issue 4, 2002, Pages 1348-1356

  Frustaci, Andrea ^a   Calabrese, Fiorella ^a,b   Chimenti, Cristina ^a   Pieroni, Maurizio ^a   Thiene, Gaetano ^a,b   Maseri, Attilio ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

Hepatitis C virus infection; Immune system; Myocarditis

Indexed keywords

AZATHIOPRINE; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; PREDNISONE; VIRUS ANTIBODY;

ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FOLLOW UP; HEART FAILURE; HEART FUNCTION; HEART LEFT BUNDLE BRANCH BLOCK; HEART MUSCLE; HEART MUSCLE BIOPSY; HEART VOLUME; HEPATITIS C VIRUS; HISTOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MUSCLE CELL; MYOCARDITIS; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SEROLOGY; TWO DIMENSIONAL ECHOCARDIOGRAPHY; VIRUS GENOME;

EID: 0036431843     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.122.4.1348     Document Type: Article

References (27)

1. Chan KY, Iwahara A, Benson LN, et al. Immunosuppressive therapy in the management of acute myocarditis in children; a clinical trial. J Am Coll Cardiol 1991; 17:458-460
2. Mason JW, O'Connell JB, Herskowitz A, et al. A clinical trial of immunosuppressive therapy for myocarditis. N Engl J Med 1995; 333:269-275
3. McKenna WJ, Davies MJ. Immunosuppression for myocarditis. N Engl J Med 1995; 333:312-313
4. Woodroof JF. Viral myocarditis: a review. Am J Pathol 1980; 101:427-479
5. Martin AB, Webber S, Fricker J, et al. Acute myocarditis: rapid diagnosis by PCR in children. Circulation 1994; 90: 330-339
6. Why HJF, Meany BT, Richardson PJ, et al. Clinical and prognostic significance of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy. J Am Coll Cardiol 1994; 24:1033-1040
7. Matsumori A, Matoba Y, Sasayama S. Dilated cardiomyopathy associated with hepatitis C infection. Circulation 1995; 92:2519-2525
8. Okabe M, Fukuda K, Arakawa K, et al. Chronic variant of myocarditis associated with hepatitis C virus infection. Circulation 1997; 96:22-24
9. Matsumori A, Matoba Y, Nishio R, et al. Detection of hepatitis virus RNA from the heart of patients with hypertrophic cardiomyopathy. Biochem Biophys Res Comm 1996; 222:678-682
10. Hackett D, Larkin S, Chierchia S, et al. Induction of coronary artery spasm by a direct local action of ergonovine. Circulation 1987; 75:577-582
11. Chimenti C, Calabrese F, Thiene G, et al. Inflammatory left ventricular microaneurysms as a cause of apparently idiopathic ventricular tachyarrhythmias. Circulation 2001; 104: 168-173
12. Aretz H, Billingham ME, Edwards WD, et al. Myocarditis: a histopathologic definition and classification. Am J Cardiovasc Pathol 1986; 1:3-14
13. Brody R, Eng S, Melamed J, et al. Immunohistochemical detection of hepatitis C antigen by monoclonal antibody TORDJI-22 compared with PCR viral detection. Am J Clin Pathol 1998; 110:32-37
14. Frustaci A, Chimenti C, Maseri A. Global biventricular dysfunction in patients with asymptomatic coronary artery disease may be caused by myocarditis. Circulation 1999; 99:1295-1299
15. Matsumori A, Yutani C, Ikeda Y, et al. Hepatitis C virus from the hearts of patients with myocarditis and cardiomyopathy. Lab Invest 2000; 90:1137-1142
16. Matsumori A. Hepatitis C virus and cardiomyopathy. Herz 2000; 25:249-254
17. Grumbach I, Heermann K, Figulla H. Low prevalence of hepatitis C virus antibodies and RNA in patients with myo-carditis and dilated cardiomyopathy. Cardiology 1998; 90:75-78
18. McGuinness PH, Bishop GA, McCaughan GW, et al. False detection of negative-strand hepatitis C virus RNA. Lancet 1994; 343:551-552
19. Takeda A, Sakata A, Takeda N. Detection of hepatitis C virus RNA in the hearts of patients with hepatogenic cardiomyopathy. Mol Cell Biochem 1999; 195:257-261
20. Durand JM, Lefevre P, Harle JR, et al. Vasculitis and cryoglobulinaemia type 2 associated with hepatitis C infection. Lancet 1991; 337:499-500
21. Johnson RJ, Gretch DR, Yarnabe H, et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 1993; 328:465-470
22. Abuaf N, Lunel F, Giral P, et al. Non-organ specific autoantibodies associated with chronic C virus hepatitis. J Hepatol 1993; 18:359-364
23. Shindo M, Di Bisceglie AM, Hoofnagle JH. Acute exacerbation of liver disease during interferon α therapy for chronic hepatitis C. Gastroenterology 1992; 102:1406-1408
24. Lisker-Melman H, Di Bisceglie AM, Usala SJ, et al. Development of thyroid disease during therapy of chronic viral hepatitis with interferon α. Gastroenterology 1992; 102:2155-2160
25. Koziel MJ. The role of the immune responses in the pathogenesis of hepatitis C virus infection. J Viral Hepat 1994; 4(suppl 2):31-41
26. Fong TL, Valinluck B, Govindarajan S, et al. Short-term prednisone therapy affects aminotransferase activity and hepatitis C virus RNA levels in chronic hepatitis C. Gastroenterology 1994; 107:196-199
27. Gutfreund KS, Bain VG. Chronic viral hepatitis C: management update. Can Med Assoc J 2000; 16:827-833